Novel cancer immunotherapies combining Affimer^® biotherapeutics and pre|CISION™ Tumour-activated chemotherapy >

Development of high performance Affimer^®-based diagnostics to improve health outcomes >

Significant long-term value, growing a pipeline of drug candidates and powerful diagnostic products >